PEAK6 Group’s Idexx Laboratories IDXX Stock Holding History

PEAK6 Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.53M	Buy	7,032 +85	+1%	+$17.5K	0.01%	1589
2018 Q1	$1.33M	Buy	6,947 +1,299	+23%	+$240K	0.01%	1698
2017 Q4	$883K	Buy	5,648 +1,511	+37%	+$238K	﹤0.01%	2024
2017 Q3	$643K	Buy	4,137 +1,575	+61%	+$249K	﹤0.01%	2333
2017 Q2	$414K	Buy	+2,562	New	+$416K	﹤0.01%	2708
2015 Q3	–	Sell	-6,926	Closed	-$496K	–	5327
2015 Q2	$444K	Buy	+6,926	New	+$479K	﹤0.01%	2893
2014 Q2	–	Sell	-7,200	Closed	-$437K	–	4834
2014 Q1	$437K	Sell	7,200 -8,042	-53%	-$479K	﹤0.01%	2678
2013 Q4	$811K	Buy	+15,242	New	+$802K	0.01%	2232
2013 Q3	–	Sell	-12,280	Closed	-$551	–	5277
2013 Q2	$551	Buy	+12,280	New	+$537K	﹤0.01%	2680

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FEF

Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

PEAK6 Group's IDXX Position: Q2 2018 in Review

PEAK6 Group increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2018, buying an estimated $17.5K and bringing the position to 7,032 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1589.

PEAK6 Group first reported a position in IDXX in Q2 2013 and has held it in 9 quarters since. 664 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

PEAK6 Group held 7,032 shares of Idexx Laboratories worth $1.53M as of Q2 2018.
PEAK6 Group bought 85 Idexx Laboratories shares in Q2 2018, an estimated $17.5K.
Idexx Laboratories made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1589 holding.
PEAK6 Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 9 quarters since.
664 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.